MBBS, MD, DM (Clinical Haematology)
Principal Director & Chief Hematology at Fortis Hospital
MBBS, MD, DM (Clinical Haematology)
Principal Director & Chief Hematology at Fortis Hospital
Cancer treatment has undergone significant advancements in recent years, and CAR T cell therapy is at the forefront of these innovations. This revolutionary treatment harnesses the power of the body’s immune system to fight cancer cells more effectively. Dr. Rahul Bhargava, a leading expert in hematology, has played a pivotal role in making CAR T cell therapy accessible to patients in India. In this blog, we will explore the benefits, risks, and expectations associated with this cutting-edge therapy.
CAR T cell therapy, or Chimeric Antigen Receptor T cell therapy, is a type of immunotherapy. It involves modifying a patient’s T cells—a type of white blood cell—to recognize and attack specific cancer cells. This personalized approach has shown promising results, particularly in treating blood cancers like leukemia and lymphoma.
CAR T cell therapy is primarily used to treat:
Research is ongoing to expand its use for other types of cancers and even some autoimmune diseases.
CAR T cell therapy offers several advantages over traditional cancer treatments:
Studies have shown remarkable success rates, especially for patients with relapsed or refractory blood cancers. Many patients achieve long-term remission.
Unlike chemotherapy and radiation, which affect both healthy and cancerous cells, CAR T cell therapy specifically targets cancer cells, reducing damage to healthy tissue.
For some patients, CAR T cell therapy has led to complete remission, offering hope where other treatments have failed.
The procedure is often performed on an outpatient basis, minimizing the need for extended hospital stays.
While CAR T cell therapy is highly effective, it is not without risks. Patients should be aware of potential side effects:
This condition occurs when CAR T cells release large amounts of cytokines, causing symptoms like fever, low blood pressure, and difficulty breathing. CRS is treatable but requires close monitoring.
Some patients experience confusion, memory issues, or seizures, which are usually temporary but can be severe in rare cases.
Since the immune system is temporarily weakened, patients may be more susceptible to infections.
As cancer cells are destroyed, they release substances into the blood that can cause complications. TLS is manageable with proper medical care.
The CAR T cell therapy process involves several critical steps:
India has emerged as a leading destination for advanced cancer treatments, including CAR T cell therapy. Dr. Rahul Bhargava, a pioneer in hematology and oncology, has been instrumental in bringing this therapy to patients in India. Here are some reasons why patients choose India for CAR T cell therapy:
Indian oncologists and hematologists, like Dr. Rahul Bhargava, are renowned for their expertise and experience in administering CAR T cell therapy.
The cost of CAR T cell therapy in India is significantly lower compared to Western countries, making it accessible to more patients.
Hospitals in India are equipped with advanced technology and infrastructure to ensure the highest quality of care.
Patients receive personalized attention and holistic care throughout their treatment journey.
Post-treatment care is a vital part of the CAR T cell therapy process:
CAR T cell therapy represents a groundbreaking advancement in cancer treatment, offering hope to patients with limited options. While the therapy comes with certain risks, its potential benefits far outweigh the drawbacks for many patients. With experts like Dr. Rahul Bhargava and India’s world-class medical infrastructure, patients can access this life-changing treatment at an affordable cost.
If you or a loved one is considering CAR T cell therapy, consult with a qualified hematologist to discuss your options and develop a personalized treatment plan.